Nathan Rubin

907 total citations
60 papers, 583 citations indexed

About

Nathan Rubin is a scholar working on Epidemiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Nathan Rubin has authored 60 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Nathan Rubin's work include Smoking Behavior and Cessation (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). Nathan Rubin is often cited by papers focused on Smoking Behavior and Cessation (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). Nathan Rubin collaborates with scholars based in United States, United Kingdom and Türkiye. Nathan Rubin's co-authors include Amrita Goyal, Kavita Goyal, Daniel E. O’Leary, Kimberly Bohjanen, Can Özütemiz, Jafar Golzarian, Shamar Young, Dorothy K. Hatsukami, Christopher L. Moertel and Robert Hong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Nathan Rubin

59 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Rubin United States 14 175 102 97 92 91 60 583
Bryce D. Beutler United States 12 78 0.4× 74 0.7× 44 0.5× 206 2.2× 103 1.1× 86 586
C. Tolédano France 13 162 0.9× 136 1.3× 94 1.0× 92 1.0× 93 1.0× 46 761
Tim Holbrook United Kingdom 9 88 0.5× 21 0.2× 104 1.1× 93 1.0× 49 0.5× 37 643
C Bologna France 19 93 0.5× 29 0.3× 70 0.7× 112 1.2× 47 0.5× 36 966
Marc Scherlinger France 16 68 0.4× 26 0.3× 52 0.5× 112 1.2× 50 0.5× 40 910
Chris Wincup United Kingdom 17 95 0.5× 21 0.2× 35 0.4× 78 0.8× 39 0.4× 52 851
Veronika Weyer Germany 17 130 0.7× 21 0.2× 80 0.8× 183 2.0× 36 0.4× 35 723
Ana Filipa Mourão Portugal 16 62 0.4× 29 0.3× 46 0.5× 48 0.5× 83 0.9× 58 983
Kate Murphy Canada 10 99 0.6× 50 0.5× 20 0.2× 313 3.4× 189 2.1× 27 799
Yarden Yavne Israel 12 276 1.6× 26 0.3× 67 0.7× 22 0.2× 168 1.8× 30 827

Countries citing papers authored by Nathan Rubin

Since Specialization
Citations

This map shows the geographic impact of Nathan Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Rubin more than expected).

Fields of papers citing papers by Nathan Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Rubin. The network helps show where Nathan Rubin may publish in the future.

Co-authorship network of co-authors of Nathan Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Rubin. A scholar is included among the top collaborators of Nathan Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Rubin. Nathan Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özütemiz, Can, Jerry Froelich, Nathan Rubin, et al.. (2024). The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppression. Annals of Nuclear Medicine. 38(5). 391–399. 1 indexed citations
2.
Rubin, Nathan, Christopher Staley, Aasma Shaukat, et al.. (2024). Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma. Scientific Reports. 14(1). 2988–2988. 9 indexed citations
3.
4.
Shetty, Mihir, Andrew C. Nelson, Britt Erickson, et al.. (2022). GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors. Cancer Research Communications. 2(8). 784–794. 8 indexed citations
5.
Nascene, David, et al.. (2022). Torcular pseudomass in newborns and its association with delivery: follow up or leave it alone?. Neuroradiology. 64(10). 2069–2076. 2 indexed citations
6.
Rubin, Nathan, Elizabeth R. Seaquist, Lynn E. Eberly, et al.. (2022). Relationship Between Hypoglycemia Awareness Status on Clarke/Gold Methods and Counterregulatory Response to Hypoglycemia. Journal of the Endocrine Society. 6(9). bvac107–bvac107. 14 indexed citations
7.
8.
Özütemiz, Can, et al.. (2021). A common yet undescribed MRI finding in newborns: posterior epidural space edema of the cervical and upper thoracic spine. Neuroradiology. 64(2). 371–379. 1 indexed citations
9.
Rubin, Nathan, et al.. (2021). Differential survival of systemic B-cell lymphomas initially diagnosed in the skin: a population-based study of 883 patients. Archives of Dermatological Research. 315(2). 259–263. 1 indexed citations
10.
Smith, Angela R., et al.. (2020). Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients. Antimicrobial Agents and Chemotherapy. 64(12). 8 indexed citations
11.
Goyal, Amrita, Nathan Rubin, Krishnan R. Patel, et al.. (2020). Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients. Archives of Dermatological Research. 313(8). 623–632. 20 indexed citations
12.
Goyal, Amrita, Daniel E. O’Leary, Kavita Goyal, et al.. (2019). Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study. Journal of the American Academy of Dermatology. 82(3). 736–738. 6 indexed citations
13.
Goyal, Amrita, Daniel E. O’Leary, Kavita Goyal, et al.. (2019). Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis. Journal of the American Academy of Dermatology. 83(2). 404–411. 36 indexed citations
14.
Gawande, Rakhee, Hamed Jalaeian, Eric Niendorf, et al.. (2019). MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction. European Journal of Radiology. 118. 88–95. 17 indexed citations
15.
Rubin, Nathan, et al.. (2019). Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins. Gynecologic Oncology. 154(2). 276–279. 12 indexed citations
16.
Rubin, Nathan, et al.. (2019). Risk factors for neo‐osteogenesis in cystic fibrosis and non‒cystic fibrosis chronic rhinosinusitis. International Forum of Allergy & Rhinology. 10(4). 505–510. 4 indexed citations
17.
18.
Özütemiz, Can, et al.. (2018). The efficacy of fluoroscopy-guided epidural blood patch in the treatment of spontaneous and iatrogenic cerebrospinal fluid leakage. European Radiology. 29(8). 4088–4095. 6 indexed citations
19.
Pierpont, Elizabeth I., Margaret Semrud‐Clikeman, Mary Ella Pierpont, et al.. (2018). Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. Journal of Neurodevelopmental Disorders. 10(1). 21–21. 31 indexed citations
20.
Allott, A. N., et al.. (1971). JAL volume 15 issue 3 Cover and Front matter. Journal of African Law. 15(3). f1–f8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryce D. Beutler Breakdown of academic impact, for papers by C. Tolédano Breakdown of academic impact, for papers by Tim Holbrook Breakdown of academic impact, for papers by C Bologna Breakdown of academic impact, for papers by Marc Scherlinger Breakdown of academic impact, for papers by Chris Wincup Breakdown of academic impact, for papers by Veronika Weyer Breakdown of academic impact, for papers by Ana Filipa Mourão Breakdown of academic impact, for papers by Kate Murphy Breakdown of academic impact, for papers by Yarden Yavne
Rankless by CCL
2026